天華新能(300390.SZ):通過與高校及研究院所開展技術合作,進行硫化物固態電解質及低成本超純硫化鋰、富鋰錳基與尖晶石鎳錳酸鋰等材料體系的研發工作
格隆匯6月26日丨天華新能(300390.SZ)在互動平台表示,公司與中科院物理所、天目湖先進儲能技術研究院、中南大學等機構的國內外頂尖電池材料研發專家緊密合作,共同研發高鎳三元、高電壓鈷酸鋰等正極材料,並已建成全自動化中試產線。公司積極關注固態電池技術發展,並根據公司業務戰略定位,以集團研究院為載體,通過與高校及研究院所開展技術合作,進行硫化物固態電解質及低成本超純硫化鋰、富鋰錳基與尖晶石鎳錳酸鋰等材料體系的研發工作。目前,已經形成工藝包及核心專利申請,部分樣品已送客户測試並獲得合格的評價結果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.